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The costs of HIV prevention strategies in
developing countries
N. SWderlund,1 J. Lavis,2 J. Broomberg,3 & A. Mills4
Since many evaluations of HIV (human immunodeficiency virus) prevention programmes do not include
data on costs, a preliminary analysis of the costs and outputs of a sample of HIV prevention projects
was attempted. Case studies, representing six broad HIV prevention strategies in developing countries
with differing levels of per capita gross domestic product, were sought on the basis of availability of data
and potential generalizability. The six prevention strategies studied were mass media campaigns, peer
education programmes, sexually transmitted disease treatment, condom social marketing, safe blood
provision, and needle exchange/bleach provision programmes. Financial cost data were abstracted
from published studies or were obtained directly from project coordinators. Although estimates of
cost-effectiveness were not made, calculations of the relative cost per common process measure of
output were compared. Condom distribution costs ranged from US$ 0.02 to 0.70 per condom distributed,
and costs of strategies involving personal educational input ranged from US$ 0.15 to 12.59 per contact.
Introduction
Despite widespread implementation of a broad range
of HIV (human immunodeficiency virus) prevention
strategies and programmes in the last decade, the
evaluation of interventions has progressed little
beyond quantifying such indicators as the numbers
of condoms distributed rather than the numbers of
cases of HIV prevented. Economic evaluation in any
form is thus poorly represented in the published
literature. This absence of rigorous evaluation of
costs and effectiveness of HIV prevention strategies
occurs against a backdrop of increasing resource
constraints and the related need to consider the
opportunity costs of any expenditure. For any given
objective or set of objectives, govemments and other
funding agencies are increasingly aware of the need
to choose the strategy or combination of strategies
bearing the least cost.
This paper presents the results of a cost analysis
of HIV prevention strategies as a step towards devel-
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oping the literature on economic evaluation. Cost
analysis can indicate relatively low-cost strategies
and provide useful information on affordability to
those who are involved in the planning, management
and evaluation of health strategies in developing
countries (1, 2). Similar disease-specific cost analy-
ses have been performed before in the health sector;
for example, Barlow & Grobar (3) reviewed the
costs of controlling parasitic diseases, and Phillips et
al. (4) reviewed the costs of selected intervention for
the prevention of diarrhoea. In addition to presenting
data on the costs and outputs of HIV prevention pro-
jects, this paper discusses some of the difficulties
faced in economic evaluation in this area, and sug-
gests directions for further research.
Methods
Case studies of currently operating programmes
representing six broad categories of HIV prevention
strategies were chosen for study. The six strategies
were:
(1) Promotion of safer sexual behaviours
through mass strategies, which usually includes
teaching essential facts about HIV, promoting
healthy behaviour, reducing anxiety about casual
transmission, and preventing discrimination against
those infected (5). This strategy usually involves
minimal targeting of vulnerable groups.
(2) Promotion of safer sexual behaviours
through person-to-person education, which involves
more intensive intervention targeted at vulnerable
groups for which the potential benefit from a given
input is perceived to be high.
Bulletin of the World Health Organization, 71 (5): 595-604 (1993) © World Health Organization 1993 595
N. Soderlund et al.
(3) Provision of condoms through social market-
ing, which encompasses market research, product
importation, branded packaging, advertising, and dis-
tribution (with retail costs often subsidized by donors
or govemment) (6).
(4) Provision of sexually transmitted disease
(STD) treatment and prevention services, which is
important because STDs both rank among the top ten
most important health problems in developing coun-
tries in terms of healthy life-years lost (7) and can
facilitate transmission of HIV (8).
(5) Prevention of unsafe drug use behaviours for
intravenous drug users (IVDUs) who are unable or
unwilling to enter drug abuse treatment programmes,
which includes education in the need to eliminate
needle sharing, instruction in disinfecting contami-
nated injection equipment, bleach distribution, and
needle exchange.
(6) Provision of a safe blood supply for transfu-
sion, which involves screening donated blood for
HIV and the disposal of infected blood.
A sample of case studies, representing each of
these HIV prevention strategies, was sought on the
basis of availability of cost and output data, and
potential generalizability. As far as possible at least
one case study for each strategy was selected from
each of the three broad income categories of devel-
oping countries as defined by the World Bank (low,
low-middle, and upper-middle income countries) (9).
In addition, a fourth category, that of eastem Europe-
an, former socialist economies, was added. Identifi-
cation of potential projects was initiated through a
combination of literature searches and interviews
with key workers in the field.
Simple costing guidelines published elsewhere
(10, 11) would have covered the requirements of this
evaluation quite adequately; in general, the difficul-
ties encountered in costing HIV prevention are simi-
lar to those encountered when studying other health
interventions. There are, however, a few features that
are relatively unique to HIV. All HIV prevention
programmes are relatively new, and cost estimates
are thus more likely to be unstable. Furthermore,
many HIV prevention programmes are small, and
appear to have been set up very rapidly with a mini-
mum of capital, often by volunteers. Under these cir-
cumstances the true economic costs are difficult to
calculate, and financial costs are almost certainly
underestimates.
A capital/recurrent cost framework was adopted
for the study. Cost data were abstracted from pub-
lished studies (when available) or obtained directly
from project coordinators using a standard form.
Only costs incurred by the providing agency were
considered; all costs falling on clients were excluded
because of the impossibility of obtaining comparable
data. Donated goods and services were valued
according to local prices. Premises, staff and equip-
ment that were shared with other programmes were
costed on the basis of estimated proportional usage.
Capital expenditures were annuitized using simple
straight-line depreciation without applying a dis-
count rate. The life-span of buildings was assumed to
be 20 years, vehicles and equipment 5 years, and
training 3 years, in accordance with guidelines pub-
lished by WHO (10). All costs were converted to US
dollars in the year incurred, and adjusted to 1990 US
dollars using United States consumer price indices
(12). While purchasing power parities would provide
more valid comparisons of some costs (13), these are
not available for most of the countries studied.
Results
Promotion of safer sexual behaviours
through mass strategies
Case studies of mass education campaigns were
taken from the Dominican Republic (A. Jimmerson,
personal communication, 1992), Gabon (J. Dubow,
personal communication, 1992), and Hungary (J.
Forrai, personal communication, 1992). The Domini-
can Republic and Gabon studies involved mass
media campaigns in the countries' largest cities.
Owing to the large size of the campaigns, the small
size of the countries, and the high proportion of the
population resident in the capital cities, the projects
were regarded as nationwide campaigns. The third
case study, the Sex Education and AIDS Prevention
Programme (SEAPP) in Hungary, involved a school-
based education programme for 11-14-year-olds in
Budapest and its environs.
The costs of the projects studied are presented in
Table 1. The costs of the two national interventions
consisted mostly of media expenditures, and show a
considerable range when expressed per capita. The
school-based education programme in Hungary was
more costly (US$ 1.33 per pupil-year of education,
which was defined as a one-hour lesson per class per
month); these costs consisted almost entirely of
teachers' salaries.
Promotion of safer sexual behaviours and
provision of condoms through person-to-
person education
The case studies selected were from Uganda, Yaoun-
de (Cameroon), Bulawayo (Zimbabwe), and Rio de
Janeiro (Brazil). The Ugandan example was a work-
place education project aimed at the 400 000
employees of 400 participating companies (F. Rwa-
kagiri, personal communication, 1992). The pro-
grammes in Yaounde (M. Mony-Lobe, personal
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Table 1: The annual cost of programmes to promote safer sex behaviours through mass
media (In US$, as of 1990)
Project Dominican Republic Gabona Hungary
Capital costs 12 993 N/A 268
(4%)b (0.4%)
Recurrent costs 425 744 N/A 63 112
Salaries 82 200 N/A 56 154
(19%) (88%)
Media costs:
Radio/TV 160 244 210 384
PrinVother 150 300 117 922 604
(71%) (92%) (1%)
Total costs 438 677 357 347 63 380
(1 00%) (1 00%) (1 00%)
Output Total pop. Total pop. Teachers trained = 140
= 7 444 000 = 1100 000 Pupils educated/year
= 41 250
Cost per output Cost per capita Cost per capita Cost per:
= 0.06 = 0.32 teacher trained
= 90.30
pupil year of education
= 1.33
a This project, which was administered under contract by a private advertising agency, included the over-
heads and salary costs within the total cost for each form of mass media.
b Percentages of the total costs are given in parentheses.
communication, 1992) and Bulawayo (S. Forsythe et
al, unpublished data, 1992) were aimed at prosti-
tutes, their clients and other vulnerable groups, while
the fourth, from Rio de Janeiro (P. Longo, personal
communication, 1992), was focused more narrowly
on male adolescent prostitutes. All projects made use
of person-to-person peer education; the Ugandan
project also used video screenings.
Costs for each project are shown in Table 2.
Capital costs for the Ugandan project were high,
consisting almost entirely of vehicles purchased to
facilitate training visits to geographically dispersed
workplaces. Salaries constituted the principal costs
in Cameroon and Brazil where the project interven-
tions were provided by full-time staff; peer educators
for the Ugandan and Zimbabwean projects were
either payed small per diems or were volunteers, and
the salary costs were consequently much lower. The
Zimbabwean project had a high proportion of non-
salary recurrent costs, primarily because most educa-
tors were volunteers, and hence the salary costs were
disproportionately low. The large number of con-
doms distributed (accounting for 27% of total costs
against 0% for the Cameroon project, where cost
recovery was achieved through condom sales) was
also a contributory factor.
Costs per condom distributed are shown in
Table 2 and range from US$ 0.10 in Zimbabwe to
US$ 0.70 in Brazil. Costs per contact established
also show a wide range (US$ 0.47 to 1.89). A cost of
US$ 25.80 per reported new condom user was calcu-
lated for the first year in the Brazil project from
results of a study done to evaluate changes in report-
ed behaviour among male prostitutes (P. Longo,
unpublished data, 1992).
Provision of condoms by social marketing
programmes
Data were obtained on ten condom social marketing
programmes, three from low-income countries
(Ghana, Indonesia and Zaire) and seven from low-
middle-income countries (Bolivia, C6te d'Ivoire,
Dominican Republic, Ecuador, Mexico, Morocco
and Zimbabwe). Only two of these (Cote d'Ivoire
and Zaire) were targeted at HIV prevention (A.
Boner, personal communication, 1992), the remain-
der being primarily contraceptive social marketing
programmes (6). It was assumed that the total costs
would be similar regardless of whether a project's
aim was disease prevention or contraception, though
different measures of effect and target coverage rates
would apply.
Cost breakdowns by type of expenditure were
available for Zaire and Cote d'Ivoire only and are
presented in Table 3. Table 4 shows costs per con-
dom sold and numbers of condoms sold for all the
countries studied. There is a broad range of costs per
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Table 2: The annual cost of projects to promote safer sexual behaviours and condom use by
person-to-person contact (in US$, as of 1990)
Project Uganda Cameroon Brazil Zimbabwe
Capital costs 18 604 0 780 307
(25%)a (2%) (0.4%)
Recurrent costs 56 410 203 600 32 770 72 220
Salaries 19 548 194 500 21 032 21 363
(26%) (96%) (63%) (30%)
Other costs 36 862 9100 11 736 50 857
(49%) (4%) (35%) (70%)
Total costs 75 014 203 600 33 550 72 527
(100%) (100%) (100%) (100%)
Outputs:
No. of condoms distributed 480 000 593 000 48 000 708 000
Other outputs Employee Educators Prostitute Contacts
contacts working contacts = 154 632
=53 400 =40 =9000
Cost per:
Condom distributed 0.21 0.34 0.70 0.10
Other output Cost per Cost per Cost per Cost per
employee educator/ prostitute contact
contact year contact = 0.47
= 1.89 = 5090.00 = 3.73
a Percentages of the total costs are given in parentheses.
condom sold (US$ 0.02 to 0.30) across different
countries. An important observation is the increase
in condom sales as the projects progressed and the
associated decrease in unit costs.
Provision of STD treatment and prevention
services
The three case studies selected offer examples of
interventions that were integrated into existing pri-
mary health care infrastructures (Maputo City and
Province, Mozambique) (14), or were free-standing
referral services (Johannesburg, South Africa) (C.
Table 3: The annual cost of providing condoms through
social marketing (in US$, as of 1990) for Zaire and CMte
d'lvoire
Location Zaire C6te d'lvoire
Capital costs 23 865 4681
(1 %). (2%)
Recurrent costs 2 043 406 263 719
Salaries 389 622 85 724
(1 9%) (32%)
Other 1 653 784 177 995
(80%) (66%)
Total costs 2 067 271 268 400
(100%) (1 00%)
Output: No. of condoms sold 18 301 507 1 828 434
Cost per condom sold 0.11 0.15
a Percentages of the total costs are given in parentheses.
Evian & I. Pinto, personal communication, 1992), or
were targeted at a specific high-risk group (prosti-
tutes in the Pumwani area of Nairobi, Kenya) (15).
The cost analysis (Table 5) shows that capital
costs were relatively low (though it should be noted
that rent was included as a recurrent cost for all
three). The bulk of recurrent costs consisted of sal-
aries and supplies (especially diagnostics, antibiotics
and condoms). The cost per visit is in the US$ 10.00
range for the two non-targeted interventions, and
significantly higher at over US$ 50 for the targeted
project in Nairobi.
Prevention of unsafe drug use behaviours
through needle exchange/bleach provision
programmes
Cost data were obtained for two case studies in devel-
oping countries (Khatmandu, Nepal and Ljubljana,
Slovenia). Since both were relatively new, small-
scale projects, a complementary case study was chosen
from the USA (Tacoma, Washington). The Khatmandu
and Tacoma case studies involved community-based
outreach, and Ljubljana a drop-in centre as well as a
24-hour telephone hotline. All data were obtained by
personal correspondence (A. Peak, 1992, Khatman-
du; H. Hagan, 1992, Tacoma; V. Flaker, 1992, Lju-
bljana).
The costs of programmes are presented in Table
6. Capital costs were low, and in the case of the
Tacoma project represented staff training and the
purchase of equipment (e.g., cellular phones and a
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Table 4: Cost per condom sold by social marketing programmes per year (in US cents, as of 1990)
Low-income countries Low-middle-income countries
Ghana Indonesia Zaire Bolivia Ecuador Mexico Morocco Zimbabwe Dom. Rep. C6te d'lvoire
Year (D)a (CP)a (D) (D) (D) (CP) (D) (D) (D) (D)
1986 4.4
(2372)b
1987 8.8 4.7 78.4
(2532) (5958) (1029)
1988 7.8 6.8 30.1 181.2 20.9
(3501) (7206) (2183) (50) (26)
1989 9.5 6.2 12.2 108.3 25.8 17.5
(3216) (7868) (1542) (280) (301) (290)
1990 7.6 1.8 59.5 5.0 28.9 16.7 7.8
(3587) (5858) (118) (3975) (1054) (769) (450)
1991 7.0 1.7 11.3 30.4 18.3 1.6 15.4 18.3 5.0 14.7
(3748) (5929) (18 302) (377) (214) (5579) (1775) (1182) (869) (1828)
Mean cost/condom sold = 6 cents Mean cost/condom sold = 15 cents
Mean duration of programmes = 5 years Mean duration of programmes = 2.9 years
a D = donated condoms; CP = commercially purchased condoms.
b Figures in parentheses are the numbers of condoms, which should be multiplied by 1000, sold per year.
vehicle) for outreach. The Nepal project relied on
street-based outreach on foot, while the Slovenian
project used a rented flat for most interactions.
Salaries and supplies (e.g., needles and syringes)
constituted the bulk of recurrent costs. The cost per
client contact ranged from US$ 2.25 in Tacoma to
US$ 3.21 in Khatmandu and US$ 12.59 in Ljubljana.
Provision of safe blood for transfusion
Case studies included two examples of national, cen-
tralized blood transfusion services: Uganda (16) and
Table 5: The annual cost of providing STD treatment
and prevention services (in US$, as of 1990)
Location Mozambique Kenya South Africa
Capital costs 0 3346 6654(0%)8 (5%) (2%)
Recurrent costs 367 600 67 293 272 830
Salaries 23 960b 17 194 165 624
(7%) (24%) (59%)
Other costs 343 640 50 099 107 206
(93%) (71%) (39%)
Total costs 367 600 70 684 279 484
(1 00%) (100%) (100%)
No. of visits 38 867 1276 27 506
Cost per visit 9.46 55.39 10.16
a Percentages of the total costs are given in parentheses.
b Only salaries of support and administrative staff are included
in this figure; clinic staff costs were included within the other
costs' category.
Zimbabwe (D. Connolly, personal correspondence,
1992). The third case study was drawn from a
hospital-based service in Monze, Zambia (S. Foster
& A. Buve, unpublished data, 1992). Under this type
of strategy, blood required for hospital inpatients
was collected only when required, so the costs for
recruitment, collection, storage and transportation
were low. However, blood is usually not available
for emergency transfusions and safety measures may
be less extensive than centralized services (in
Monze, blood was screened only for HIV and not for
hepatitis B or syphilis). In all three examples, blood
was screened anonymously and donors were not
informed of the result of the test.
Table 6: The annual costs of programmes preventing
unsafe drug use behaviours (in US$, as of 1990)
Location Nepal Slovenia USA
Capital costs 0 0 6009
(0%). (0%) (4%)
Recurrent costs 7333 18 889 140 517
Salaries 3567 13 575 97 813
(49%) (72%) (67%)
Other costs 3766 5314 42 704
(51%) (28%) (29%)
Total costs 7333 18 889 146 526
(100%) (100%) (100%)
No. of client contacts 2287 1500 65 000
Cost per client contact 3.21 12.59 2.25
a Percentages of the total costs are given in parentheses.
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The costs of ensuring a
services studied are shown i
per unit of blood produc
of US$ 20.90 in the ho
US$ 34.50 and US$ 51.60 1
Ugandan blood transfusior
The cost of HIV safety per x
culated by adding the costs
staff time, laboratory overhe
costs of blood discarded be
For comparative purposes, t
rate was scaled up to reflec
the Zimbabwean rate, and ti
capita calculated.
Discussion
Methodological shortcoi
A number of potential meth
need to be bome in mind ir
sing the results. These coni
data obtained, the valuation
currency, and the potentia]
results.
The accuracy of the rei
estimate. There were no sta
categories or systematic on
most case studies reviewe
involved the imposition of
diversely organized data set
spectively by the project c(
visits, we were unable to
Table 7: The annual cost of pi
ply (in US$, as of 1990)
Location U1
Cost per unit produced
Cost of HIV safety per unit
produced:
Counselling
HIV screening
Confirmatory tests
Replacement of infected blooc
Total
Donor HIV seroprevalence
Units produced per year
Units produced per capita of
population (for national
programmes only)
Cost of HIV safety per capita
of population (assuming blooc
usage at Zimbabwe rate)
a N/A: not applicable.
safe blood supply in the data provided. However, whenever possible, uncer-
n Table 7. The total cost tainties were clarified by telephone with local staff.
ad ranged from a low The conversion of all costs to constant US$
spital-based service to using the 1990 exchange rates and US consumer
.or the Zimbabwean and price indices may have under- or overestimated theiservices, respectively. real value of inputs, especially labour, in developing
unit produced can be cal- countries. However, the lack of purchasing power
of HIV testing materials, parity data necessitated this approach. This problem
ads, and the replacement is by no means unique to this study.
cause of a positive test. A number of factors might limit the generaliz-
he Ugandan blood usage ability of the results. An attempt was made to
t per capita blood use at include a reasonably representative set of pro-
ie cost of HIV safety per grammes, but ultimately case studies were included
primarily on the basis of availability of data and
therefore reflect a convenience sample which may be
subject to selection bias. It is possible that pro-
grammes with better cost data are better organized
nings and more efficient than is generally the case. Theflings feasibility and costs of interventions will be influ-
iodological shortcomings enced by the political and economic climate and the
l interpreting and discus- geographical and social accessibility of target groups
cern the accuracy of the in the country, as well as by the local price structureion inputs in a common and degree of development of the infrastructure that
I generalizability of the the project can draw on (17).
Nevertheless, the scanty published data on simi-
)orted data is difficult to lar types of intervention for other diseases do indi-
ndard definitions of cost cate a range of costs of similar orders of magnitude.
[going data collection in For example Shepherd (18) compared the costs of
d. Hence cost analysis two mass education campaigns for diarrhoeal disease
a costing framework on control in the Gambia and Honduras. Total costs per
ts, often developed retro- annum were US$ 233 322 and US$ 422 500 respec-)ordinators. Without site tively, which are similar to those found here for mass
verify independently the strategies to promote safer sexual behaviour. A
school-based hygiene promotion campaign in Indo-
nesia cost US$ 1.87 per pupil-year of education (19),
roviding a safe blood sup- which is similar to that found in the SEAPP project.
Comparison of the case studies of STD treatment
ganda Zambia Zimbabwe and prevention services with available data on the
costs of an outpatient visit in developing countries51.6 20.9 34.5 (averaging around US$ 5 to 7 in 1988 prices, Bar-
num & Kutzin, unpublished data, 1993) suggests that
- - 0.21 the case studies are of similar magnitude but on the
5.7 5.1 2.1 expensive side.
7.6 4.0
0.23
1.3 Influence of strategy
10%. Z. 3.8 The costs of programmes to promote safer sexual
20% 20% 3.8% behaviours through mass strategies are highly
11 410 1500 60 000
variable. Costs per capita in the Gabon project
(US$ 0.32) were considerably higher than in the
7/10 000 N/Aa 61/10 000 Dominican Republic (US$ 0.06), but total costs were
pop. pop. similar, suggesting economies of scale resulting from
different population sizes. The number of people
reached through a mass media campaign, however,
0.078 N/A 0.024 is often difficult to quantify. The higher cost per
pupil-year of education for the school education
WHO Bulletin OMS. Vol 71 1993
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project reflects the greater intensity of contact under
this type of programme.
Large variations in costs and the quality of mass
media campaigns have been documented for similar
interventions aimed at breast-feeding (4) and oral
rehydration (18). Production costs have been found
to vary from US$ 175 to 50 000 for one hour of tele-
vision (20), and although production costs for radio
are considerably cheaper, the latter may still vary
two- to threefold between countries (21). Broadcast-
ing costs are highly variable and may be very low or
free in countries with state-run broadcasting systems
or laws requiring commercial stations to provide free
airtime for educational programmes (e.g., Brazil). At
the opposite extreme, projects may have to purchase
time at normal advertising rates on private commer-
cial networks at an exorbitant cost. Several studies
document convincing changes in knowledge and atti-
tudes regarding safer sexual behaviours as a result of
mass strategies (22), but the evidence for changes in
behaviour is less convincing (5).
The promotion of safer sexual behaviours and
provision of condoms through person-to-person con-
tact are for obvious reasons more expensive per con-
tact than mass media campaigns. Factors influencing
the cost of the former include the total number of
persons targeted and the social and geographic
accessibility of the target groups. The difference in
cost per condom distributed between the Cameroon
and Zimbabwean projects may also partly have been
because of the charge for condoms distributed in
Cameroon, and hence a lower demand.
In condom social marketing programmes, costs
appeared to decline significantly as the projects pro-
gressed, and began to level out after 3-5 years. The
high costs in the initial years were due to the start-up
costs for baseline market research, project design and
project launch, as well as the low numbers of con-
doms sold. Unit costs dropped sharply as condom
sales began to rise. Although the mean cost per con-
dom sold was significantly less in low-income coun-
tries (US$ 0.06) than in low-middle-income coun-
tries (US$ 0.15), this was probably because of the
longer mean age of projects in low-income countries
(5 years as against <3 years for low-middle-income
countries).
There was also considerable variation in condom
social marketing costs between projects of similar
age, which was attributable partly to market size and,
probably more importantly, to the condom-source
model used. The model used in Indonesia involved
the importation of condoms by a private partner via
commercial channels and the use of donor funds to
build the market through advertising and promotion.
A second model, used in Mexico, Ecuador and
Morocco, involved initial donation of condoms, with
a switch to commercial purchase over three to five
years. The final model (in Bolivia, COte d'Ivoire,
Dominican Republic, Ecuador, Ghana, Morocco,
Zaire and Zimbabwe) used only donated condoms.
Data were not sufficient to detect any difference in
unit costs between primarily contraceptive and pri-
marily HIV-prevention programmes, but these could
feasibly have existed.
Price can have a significant impact on per capita
sales and the potential for cost recovery. The price of
condoms (expressed as a proportion of a daily wage)
accounts for a large proportion of the variation in per
capita sales across programmes (23). Such an effect
suggests that price must be kept as low as possible to
generate sufficient demand among target consumers
while at the same time allowing some form of cost
recovery if sustainability and self-sufficiency is to be
achieved. The Indonesian DuaLima Red condom
project is currently self-sufficient and the Moroccan
and Mexican projects are likely to become so in the
near future. It is unlikely, however, that projects in
most low-income countries will become self-sustain-
ing in the foreseeable future, as they lack a well-
developed commercial infrastructure, access to for-
eign exchange and/or the potential for cost recovery.
Cost recovery, volume of sales, and wastage rates
(which are likely to vary according to price) must all
be carefully considered and balanced in project plan-
ning and management.
The cost per visit for STD services was in the
US$ 10.00 range for non-targeted programmes,
regardless of whether they were horizontally or verti-
cally structured, but the data are inadequate to com-
pare these altematives. The far higher cost per visit
for the targeted intervention in Nairobi reflects the
relatively small target population, with only 1270
visits to the service per year. Applying an epidemi-
ological model of HIV transmission to Kenyan data,
Moses et al. (12) argued that for US$ 8.00 to 12.00,
an intervention targeted at a high frequency core
transmitter group could prevent one case of HIV. It
is important to emphasize, however, that most of this
effect is related to the use of condoms and not direct-
ly to the diagnosis and treatment of conventional
STDs. The authors argued, however, that in the
absence of effective and accessible health services, it
is unlikely that clients would be as receptive to the
programme's efforts in health education and promo-
tion.
The variations in costs per client contact for pre-
vention of unsafe drug use behaviours are likely to
primarily reflect differences in the length of opera-
tion of the projects and resulting numbers of clients.
The Tacoma needle exchange project had been in
operation for five years, while the Khatmandu sterile
needle exchange and the Ljubljana stigma projects
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had been operational for only 1 year and 5 months,
respectively, at the time data were collected. Similar-
ly, unit costs would be expected to vary with differ-
ent sizes of IVDU populations in the area served.
The costs of providing safe blood for transfusion
in different countries appear to depend on a number
of fairly easily identifiable factors, and have been
well described elsewhere (24). The Ugandan costs
(total per unit produced and of HIV safety per unit
produced) are highest partly because of the high cap-
ital costs incurred in setting up the programme from
nothing, but also because of the high HIV seropreva-
lence in the donor population. While the total cost
per unit in Zimbabwe is higher than in Zambia
(Monze), the cost of HIV safety is considerably
lower. This difference is likely to be attributable to
the substantially lower HIV seroprevalence amongst
Zimbabwean donors, as well as economies of scale
associated with bulk testing in Zimbabwe.
The principal factors affecting the costs of pro-
viding safe blood for transfusions would thus appear
to be, firstly, the HIV seroprevalence among blood
donors. This is in turn dependent on the overall pop-
ulation prevalence and the way in which donors are
recruited. Secondly, the structure of the blood trans-
fusion service (whether it is hospital-based or cen-
tralized) appears to be important. The relative costs
of these two approaches may vary depending on
national geography and transportation infrastructure,
availability of skilled technical staff, minimal accept-
able quality guidelines and rural/urban differences in
HIV seroprevalence. Other factors affecting blood
safety costs include the size of the blood transfusion
service, since economies of scale are likely to exist,
and the blood-testing protocol used (i.e., whether or
not donors are informed of their results, and thus
require pre-and post-test counselling).
Comparisons between strategies
The current poor level of knowledge about effective-
ness of HIV prevention strategies allows us only to
make rough comparisons of the cost by process indi-
cator, such as cost per condom distributed and cost
per person reached by educational campaigns. The
degree to which such process indicators reflect effec-
tiveness in terms of numbers of cases of HIV preven-
ted is open to question. Comparing programmes
which involve condom distribution shows a broad
range of costs per condom distributed for person-to-
person initiatives (US$ 0.10 to 0.70), while condom
social marketing projects operating for three years or
longer have a narrower and clearly lower range of
costs (US$ 0.02 to 0.18). Person-to-person peer-
education programmes were more expensive per
educational contact (US$ 0.47 to 3.73) than the
school education programme (US$ 0.15 assuming 9
classes per year), but cheaper than needle exchange/
bleach provision programmes (US$ 2.25 to 12.59).
However, comparisons using common process
measures of effect may be inappropriate if they do
not reflect the principal aim of the intervention. For
example, although the number of condoms distribut-
ed by person-to-person education projects was meas-
ured, this was not the primary objective of the strat-
egy. A comparison with condom social marketing,
which measures success by numbers of condoms
sold, may thus be unfair.
Moreover, strategies involving educational con-
tact, such as mass-media and person-to-person inter-
ventions, vary significantly in the intensity, and
probably also the quality, of contact established.
Hence, their effect on behaviour is also likely to dif-
fer. Furthermore, the effectiveness of either strategy
is dependent on the relative risk of the person con-
tacted, and this clearly differs between, for example,
schoolchildren and vulnerable groups such as prosti-
tutes and intravenous drug users. Strategies which
involve condom distribution through social market-
ing appear cheaper than person-to-person education,
but it is not known whether socially marketed con-
doms reach the same vulnerable groups targeted in
person-to-person campaigns, or if wastage rates are
lower if condoms are purchased rather than received
free. Different strategies displace the costs onto the
recipients of services to different degrees. Because
we have only measured the costs incurred by pro-
viders, programmes which involve cost-sharing
may seem more efficient than they really are.
Conclusion
Govemments and donors currently face significant
problems in deciding on the appropriate allocation of
resources between various HIV prevention strategies.
Economic evaluation is just one tool which can
help policy-makers to make these decisions. The
current absence of a common output or effectiveness
measure renders rigorous comparisons between
different strategies impossible.
Cost-effectiveness analysis thus still represents a
significant gap in HIV research which will be filled
only by a concerted reorientation of evaluative
efforts over a number of years. This analysis, how-
ever, has provided a preliminary insight into the fin-
ancial costs and output of a sample of HIV preven-
tion projects which will help funding agencies,
national governments and project workers to plan
and budget for future activities. It also allows an
estimation of the relative cost per process measure of
effect for strategies which have in common either
personal education or condom distribution.
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Furthermore, this study suggests a research
agenda for the economic evaluation of HIV preven-
tion strategies. Firstly, much effort is needed to build
on this groundwork in order to develop a database of
costs which could help guide the planning, manage-
ment and evaluation of HIV prevention projects at
district, national and international levels. Multiple
national research initiatives would circumvent some
of the weaknesses associated with the valuation of
inputs (such as exchange rates) and programme
effectiveness in different environments, but require
costly duplication of research efforts. An internation-
al database could provide estimates of the total costs
and cost structures of strategies, which could then be
interpreted in the light of prevailing local conditions.
Requiring the collection of cost data in project evalu-
ations would help other projects and also allow pro-
gramme planners and managers to make better
informed decisions when reviewing programme per-
formance or when initiating programme expansion.
Secondly, we would hope this analysis gives
impetus to efforts to use cost data in conjunction
with epidemiological simulation models in order to
model the cost-effectiveness of alternative strategies.
As more data on behavioural change and transmis-
sion dynamics accumulate, these new findings could
be used to further refine the models. Such an
approach seems the only realistic way to estimate
and compare cost-effectiveness in the immediate
future.
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Resume
Le cout des strat6gies de pr6vention de
l'infection A VIH dans les pays en
d6veloppement
Des 6tudes de cas repr6sentatives de six grandes
strategies de prevention de l'infection a VIH ont
e selectionn6es dans quatre groupes de popula-
tion dans des pays de niveaux economiques diffe-
rents (faibles revenus, tranche inferieure des
revenus interm6diaires, tranche sup6rieure des reve-
nus interm6diaires, anciennes 6conomies socia-
listes). Ce choix a et6 effectu6 en tenant compte
de la disponibilite des donnees, de l'efficacite des
programmes et des possibilites de gen6ralisation.
Les donn6es relatives aux coOts ont ete extraites
de la litterature ou obtenues directement aupres
des coordinateurs de projets a I'aide d'un ques-
tionnaire normalise. Seuls les coOts du secteur
public ont ete inclus dans I'analyse apres avoir
ete convertis en dollars des Etats-Unis aux taux
de 1990 pour faciliter les comparaisons.
Les coOts des programmes d'education de
masse visant a favoriser les comportements
sexuels a moindres risques sont extremement
variables ($US 0,06 a 0,32 par personne); le coOt
total et le coOt unitaire sont du meme ordre de
grandeur que pour les campagnes entreprises
dans les medias pour lutter contre les maladies
diarrheiques. Les 6conomies d'echelle peuvent
etre importantes et dependent de la taille des
populations. La promotion des comportements
sexuels a moindres risques et la fourniture de pre-
servatifs a l'occasion de campagnes d'education
personnalisee semblent plus coOteuses ($US 0,47
a 3,73 par personne contact6e), mais cette strate-
gie permet probablement un meilleur contact. Les
coOts d6pendent de la taille et de l'accessibilite du
groupe cible.
Lorsque les preservatifs sont distribues dans
le cadre de campagnes de commercialisation a
but social, le coOt unitaire diminue a mesure que
le projet avance. Le coOt de chaque preservatif
vendu ($US 0,02 a 0,30) depend aussi de la taille
du march6 et du mode d'acquisition des preserva-
tifs, les coOts les plus faibles 6tant observ6s
lorsque le secteur public est associe a des parte-
naires du secteur prive. Lors de l'6tablissement du
prix, il faut trouver un compromis entre le recou-
vrement des coOts (qui a des incidences sur la
viabilit6 du projet) et le taux de couverture (un
prix eleve peut avoir un effet dissuasif, tandis
qu'un prix d6risoire favorise le gaspillage).
Les services de traitement et de prevention
des maladies sexuellement transmissibles se sont
revel6s plus coOteux ($US 9,46 a 55,40 par visite)
que ne le laissaient prevoir les donn6es dispo-
nibles sur le coOt des soins de sante primaires
dans les pays en developpement, ce qui donne a
penser que les 6tudes de cas retenues 6taient
particulierement coOteuses. Mais ces services, en
plus de pr6venir l'infection a VIH, guerissent aussi
des maladies qui ont leur propre morbidit6 et mor-
talite.
II est normal que le coOt unitaire initial de la
prevention des comportements a risque chez les
utilisateurs de drogues grace a des programmes
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d'echange d'aiguilles et de distribution de d6sin-
fectant soit 6lev6, car il faut du temps pour recru-
ter la clientele cible. En fait, ces coOts ont varie
de $US 2,25 a 12,59 par contact. La fourniture de
sang non contamine est le seul exemple de stra-
t6gie dont le coOt unitaire varie notablement selon
le niveau de pr6valence, car une pr6valence ele-
v6e augmente le coOt de remplacement des lots
de sang contamine. Des economies d'echelle sont
certainement possibles pour les programmes
nationaux. Certains programmes r6alis6s a 1'eche-
Ion hospitalier peuvent etre moins coOteux, mais
la qualit6 risque d'en souffrir.
Cette analyse ouvre la voie a l'elaboration
d'une base de donn6es sur le coOt des strat6gies
de pr6vention qui servira de guide pour la planifi-
cation, la gestion et l'evaluation des interventions
au niveau local, national et international. Elle per-
mettra aussi d'6valuer le coOt relatif, en fonction
des r6sultats obtenus, des diff6rents modeles de
mise en ceuvre des strat6gies fond6es sur la dis-
tribution de pr6servatifs ou l'6ducation. Enfin, elle
donne des informations qui pourront etre utilis6es
a l'avenir dans des modeles de simulation 6pid6-
miologiques pour estimer le rapport cout/efficacite
d'un projet.
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